2C-I

Also known as 2,5-dimethoxy-4-iodophenethylamine, Cimbi-88, 25I, 4-iodo-2,5-dimethoxy-beta-phenethylamine, 4-iodo-2,5-dimethoxy-β-phenethylamine, 4-iodo-2,5-dimethoxyphenethylamine, 2-(4-iodo-2,5-dimethoxyphenyl)ethan-1-amine

2C-I, also known as 4-iodo-2,5-dimethoxyphenethylamine, is a psychedelic drug of the phenethylamine and 2C families. It is taken orally.

Key facts

Drug.Verifiedfields: verified
Drug.Watchedfields: verified
Drug.verifiedrevid: 477216266
Drug.image: 2C-I2DACS.svg
Drug.image_class: skin-invert-image
Drug.width: 200px
Drug.image2: 2C-I-3d-sticks.png
Drug.image_class2: bg-transparent
Drug.width2: 200px
Drug.routes_of_administration: Oral
Drug.class: Serotonin 5-HT2 receptor agonist; Serotonin 5-HT2A receptor agonist; Serotonergic psychedelic; Hallucinogen
Drug.ATC_prefix: None
Drug.legal_AU: Schedule 9
Drug.legal_BR: F2
Drug.legal_CA: Schedule III
Drug.legal_UK: Class A
Drug.legal_US: Schedule I
Drug.onset: ≤40 minutes

via Wikipedia infobox

~6 min read

Encyclopedic overview

20 sections

Contents

Use and effects
Interactions
Pharmacology
Pharmacodynamics
Chemistry
Synthesis
Analogues
History
Society and culture
Legal status
Australia
Canada
European Union
Finland
Sweden
United Kingdom
United States
See also
References
External links

2C-I, also known as 4-iodo-2,5-dimethoxyphenethylamine, is a psychedelic drug of the phenethylamine and 2C families. It is taken orally.

2C-I was first synthesized and described by Alexander Shulgin in 1977 and was described in further detail in his 1991 book PiHKAL (Phenethylamines I Have Known and Loved). The drug is used recreationally. 2C-I is sometimes confused with other related psychedelic drugs such as 25I-NBOMe (NBOMe-2C-I), nicknamed "Smiles" and "N-bomb" in the media.

Excerpted from Wikipedia’s “2C-I” article, available under the CC BY-SA 4.0 licence.

Gallery (2)

Available in 17 languages

via Wikidata sitelinks · CC0